Drug Type Biosimilar, Enzyme |
Synonyms Alteplase Biosimilar (Scienture Holdings, Inc.), 阿替普酶生物类似药(Scienture Holdings, Inc.), SCN-106 + [1] |
Target |
Action stimulants |
Mechanism PLG stimulants(Plasminogen stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Embolism and Thrombosis | Preclinical | United States | 13 Jan 2025 |






